Transplacental delivery of maternal thyroid hormones to the fetus, in particular thyroxine (T 4 ), is critical in ensuring normal fetal neurological development. The fetus relies on maternal T 4 till around 16 weeks gestation, but mechanisms of placental T 4 transport are not yet fully elucidated. Placenta produces, secretes and takes up the thyroid hormone-binding protein transthyretin (TTR). Many placental genes are regulated by oxygen levels, which are relatively low (1%) in the early first trimester, rising to 3% in the mid first trimester and 8% in the early second trimester and thereafter. We examined the expression and uptake of TTR in isolated primary human placental cytotrophoblast cells cultured under different oxygen concentrations (1, 3, 8, 21% O 2 and 200 mM desferrioxamine (DFO)) for 24 h. We observed sevenfold higher expression of TTR mRNA and protein levels at 1% O 2 than at 8 and 21% O 2 . Significant increases were observed after culture at 3% O 2 and following DFO treatment. We observed significantly higher uptake of 125 I-TTR and Alexa-594-TTR when cells were cultured at 1 and 3% O 2 and in the presence of 200 mM DFO than at 8 and 21% O 2 . When JEG-3 choriocarcinoma cells were transfected with TTR promoter reporter constructs, increased luciferase activity was measured in cells cultured at 1 and 3% O 2 in comparison to 8 and 21% O 2 . We conclude that placental TTR expression and uptake is increased by the relative hypoxia observed in the first trimester of pregnancy, a time when materno-fetal T 4 transfer is the sole source of fetal T 4 .
Introduction
Thyroid hormone, in particular thyroxine (T 4 ), plays an important role in the activation, differentiation and maturation of the fetal central nervous system (Bernal 2005 , Patel et al. 2011b . Before 16 weeks gestation, the fetus relies solely on transplacental delivery of maternal T 4 (Obregon et al. 2007) . By 6 weeks gestation, measurable amounts of T 4 and T 3 have been detected in human fetal coelomic fluid and there is evidence to suggest that even after the onset of fetal thyroid function, transport of T 4 from maternal to fetal circulation continues (Vulsma et al. 1989 , Patel et al. 2011a . Rat experiments suggest that fetal brain development preferentially requires T 4 , which is locally deiodinated to T 3 (Calvo et al. 1990) . Clinical studies suggest that even mild reductions in maternal T 4 adversely affect the intellectual function of offspring, indicating that human brain development is very sensitive to mild maternal hypothyroidism (Haddow et al. 1999) . The biological corollary of these clinical and animal studies is that a maternal to fetal T 4 transfer system must operate in very early human pregnancy. Some of the components of this putative system and its possible regulation (trophoblast cell membrane thyroid hormone transporters, placental type III deiodinase and possibly transthyretin (TTR)) are known but the mechanisms of thyroid hormone transfer and its regulation are yet to be elucidated (Patel et al. 2010a) .
We have recently reported that human trophoblast cells produce the T 4 and retinol-binding protein, TTR (McKinnon et al. 2005) . Studies on polarised choriocarcinoma JEG-3 cells maintained in bicameral chambers indicate that TTR is secreted apically and basally (Landers et al. 2009 ). Trophoblasts also take up TTR from culture medium and this uptake is increased when T 4 is bound to TTR, increasing TTR tetramer formation (Landers et al. 2009 ). These findings raise the possibility that placental TTR is involved in a transplacental T 4 shuttle system.
The early placenta is marked by low oxygen levels (1%) that increase as placental vascularisation is established so that by 12 weeks gestation placental oxygen levels reach 8%, a concentration that in normal pregnancies is maintained until term (Schneider 2011) . Many placental genes and placental development itself are regulated by changing oxygen levels throughout gestation (Patel et al. 2010b) . We have recently demonstrated in JEG-3 cells that TTR mRNA expression, protein levels and uptake are increased at the lower oxygen levels found in the early placenta (Patel et al. 2010a) .
Therefore, the aim of this study was to investigate the TTR expression and uptake by isolated human term trophoblasts cultured under different oxygen concentrations reported in the developing human placenta to confirm our previous findings in JEG-3 cells. We also measured TTR promoter activity in JEG-3 cells cultured under different oxygen concentrations. We postulate that TTR expression and uptake in primary trophoblast cells will increase at low oxygen levels, as suggested by our previous work on JEG-3 cells.
Methods and Materials

Placental tissue
Placentas from term (38-39 weeks; nZ12) normal healthy women undergoing caesarean section at the Royal Brisbane and Women's Hospital were collected, with informed consent, soon after delivery. This study was approved by the Royal Brisbane and Women's Hospital and Queensland Institute of Medical Research Human Research Ethics Committees.
Isolation of cytotrophoblast cells from placental tissue
Villous cytotrophoblasts were isolated as described previously (Kliman et al. 1986 , Greenwood et al. 1996 , Barber et al. 2005 . Isolated cytotrophoblasts were cultured in DMEM:F12 nutrient mixture, 25 mM HEPES and 1% L-glutamine (all from Sigma), supplemented with 1% penicillin/streptomycin, 0 . 1% plasmocin and 10% FCS (all from Invitrogen). Cytotrophoblasts were seeded onto sterile coverslips in 24-well culture plates and fixed for immunocytochemical staining of cytokeratin-7 to determine purity of the cell population.
Low oxygen experiments
Isolated cytotrophoblasts were simultaneously seeded at 3! 10 6 cells in a 6-well culture plate and cultured for 4 days. From days 1 to 3, the cells were grown under standard laboratory culture conditions at 21% O 2 . On day 3, the cells were transferred to Heraeus HeraCell incubators (Thermo Scientific, Langenselbold, Germany) and maintained at different oxygen concentrations of 1, 3 and 8% for 24 h. Cells were also studied at 21% O 2 , which is standard laboratory practice and routine for placental cell function studies. Desferrioxamine (DFO; 200 mM), a hypoxic mimetic drug, was used as a positive control (Li et al. 2011) . DFO, a hypoxia mimetic drug, was used in this study as a positive control and has been used in JEG-3 cells in other studies at similar concentrations without affecting cell viability (Patel et al. 2010a) . DFO is an iron chelator and mimics hypoxia by inhibiting prolyl hydroxylases, which are essential for the proteasomal degradation of hypoxia-inducible factor-1a (HIF-1a) during times of normoxia (O5% O 2 ), resulting in the nuclear accumulation of HIF-1a and downstream effects (Ran et al. 2005) . DFO has been used extensively in many cell and tissue types and is recognised as the gold standard for creating a hypoxic environment under normoxic conditions (Ran et al. 2005 , Takeda et al. 2007 , Chu et al. 2010 . Viability of cells used in the experiment was assessed on day 4 by measurement of human chorionic gonadotrophin (hCG) and lactate dehydrogenase (LDH) in cell culture medium. hCG is a marker of trophoblast function and LDH secretion is elevated when cellular material breaks down. hCG and LDH were measured by Chemical Pathology, Pathology Queensland. hCG was measured using the Beckman Coulter Access Immunoassay Total bhCG system (intra-assay coefficient of variation (CV) 4 . 1%; inter-assay CV 4 . 6%). LDH was measured using the Beckman Coulter SYNCHRON LX system with the SYNCHRON enzyme validator set (intraassay CV 3 . 5%; inter-assay CV 7 . 3%).
Quantitative RT-PCR
On day 4, following 24 h of culture at low oxygen or treatment with DFO, total RNA was extracted from the trophoblast cells using the RNAeasy Mini Kit (Qiagen). Total RNA (4 mg) was reverse transcribed to produce cDNA using the Superscript III RT Kit (Invitrogen) and P(dt) 15 primers (Roche Applied Sciences) in a reaction volume of 20 ml.
Quantitative PCR was performed using 0 . 5 mM of forward and reverse primers with FastStart SYBR Green master-mix in a 15 ml reaction, which included 3 ml cDNA (Roche Applied Sciences) in a Rotor Gene RG-3000 (Corbett Research, Sydney, NSW, Australia). The real-time PCR method was validated by using serially diluted cDNA as a standard curve. To quantify the mRNA expression profile in each sample, the efficiency of each standard curve was determined by its slope and comparative threshold according to the manufacturer's instructions. For each sample, the amount of targeted mRNA (AU) was normalised to the housekeeping gene b-actin. mRNA quantification was performed using the Pfaffl method (Pfaffl et al. 2002) , which makes no distributional assumptions. The primers used to amplify specific mRNAs are listed in Table 1 . 
Brefeldin A treatment
On day 3, isolated trophoblast cells grown in 6-well cell culture flasks were incubated overnight in serum-free (SF) media. On day 4, the cells were then cultured in SF mediaG10 mg/ml brefeldin A for 6 h. Brefeldin A inhibits the transport of proteins from the endoplasmic reticulum (ER) to the Golgi apparatus, leading to the accumulation of protein with the ER, preventing secretory proteins such as TTR from being released (Klausner et al. 1992) . SF media was used since serum contains TTR and other proteins that may interfere with the experiment. Total cell lysates were collected and analysed by western blotting, with each experiment carried out in triplicate. Brefeldin A had no adverse effects on cell viability as determined by trypan blue exclusion. This experiment was carried out under the same oxygen conditions as described previously.
TTR labelling
TTR (Sigma) was labelled with 125 -Iodine ( 125 I) using the chloramine-T method by John Bellen, Department of Nuclear Medicine, Royal Brisbane and Women's Hospital (Greenwood et al. 1963) . Fluorescent labelling of TTR (Alexa-TTR) was performed with an Alexa-Fluor-594
Labelling Kit according to the manufacturer's instructions (Invitrogen).
I-TTR membrane binding and internalisation
On day 3, isolated trophoblast cells were transferred to 1, 3, 8, or 21 O 2 G 200 mM DFO for 24 h in 6-well plates prior to uptake studies on day 4; each experiment was carried out in triplicate. Binding and internalisation studies were performed as described previously (Landers et al. 2009 ). Cells were washed with PBS and cultured in SF-DMEM for 4 h before incubation with 125 I-TTR (10 pM) in SF-DMEM containing 100 mM potassium perchlorate at 37 8C. Incubation with an excess of unlabelled TTR (1 mM) was used to distinguish between specific/non-specific binding and internalisation. T 4 (10 mM) was used as described previously (Landers et al. 2009 ). Cells were incubated in a 21% O 2 incubator for 1 h to allow binding and internalisation to occur. After 1 h, the media was removed and cells washed in ice-cold PBS. Surface bound proteins were removed using ice-cold 0 . 025% trypsin/0 . 01% EDTA as described previously (Divino & Schussler 1990 , Landers et al. 2009 ). Internalised TTR was collected by harvesting cells with 1 M NaOH for 5 min at 37 8C. Samples were counted in a Packard Cobra II series counter (Hewlett Packard, Blackburn, VIC, Australia), with a counting efficiency of 80 . 27%.
Alexa-TTR internalisation
On day 3, isolated cytotrophoblast cells were transferred to SF-DMEM for 16 h before incubating the cells with 100 mg/ml Alexa594-TTR for 1 h. Uptake of Alexa-TTR was evaluated in the presence of 1 mM unlabelled TTR and 10 mM T 4 (Landers et al. 2009 ). Cells were washed with cold PBS before fixation in 4% paraformaldehyde. Counterstaining with DAPI and phalloidin were conducted to mark nuclei and actin filaments respectively. Images were captured using Deltavision Core Technology (Applied Precision, Washington, DC, USA). To ensure identical image analysis for the comparison of TTR uptake was undertaken, all slides from the same experiment were scanned using the same settings including u.v. light transmission and exposure time. Captured images were displayed with the same intensity scale for channel of Alexa-Fluor594 labelled TTR. Using ImageJ Software (National Institutes of Health, NIH), individual cells (nZ30) were randomly selected, magnified and the intracellular TTR-labelled foci (red) counted.
Preparation of TTR promoter constructs
Upstream regions (0 . 11, 0 . 65 and 2 . 1 kb) of the human TTR gene (Mirkovitch & Darnell 1991) were ligated into the pGL3-basic vector between the KpnI and NheI sites (Promega). The following primers were used: 0 . 11 kb
and 2 . 1 kb (5 0 -GGCGGTACCTAACATATCTATGGGCT-GATG-3 0 ). The following reverse primer was used for all three sequences (5 0 -TATCGCTAGCAGGAGCAGACGAT-GAGAAGC-3 0 ). The constructs were designated pGL3-0 . 11 kb (0 . 11 kb insert), pGL3-0 . 65 kb (0 . 65 kb insert) and pGL3-2 . 1 kb (2 . 1 kb insert). The TTR promoter constructs were cloned using JM109 Escherichia coli and the vector (plasmid) DNA was extracted using the Qiagen Plasmid Midi Kit (Qiagen). Quality of plasmid DNA (pDNA) extracted was measured for concentration and purity using A260/A280 spectroscopy on the Nanodrop ND-1000 machine (Thermo Scientific).
Luciferase assays
JEG-3 cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and maintained in DMEM (Sigma) with 1% penicillin/streptomycin, 0 . 1% plasmocin and 10% fetal bovine serum. Once confluent, JEG-3 cells were plated onto white flat bottom 96-well plates (Perkin Elmer, Glen Waverley, VIC, Australia) with regular culture medium. On day 2, the cells were transfected with a total of 0 . 33 mg pDNA per well. The transfection mixture contained 300 ng empty pGL3 vector or pGL3 containing the TTR promoter insert with 30 ng of the internal control vector (pRL-TK), at a ratio of 3:1 with FuGENE 6 transfection reagent (Roche), according to the manufactures' instructions. Transfection mixture (100 ml) was added to each appropriate well. Transfected cells were cultured under the same low oxygen conditions previously described for a further 24 h. The luciferase reporter assay was conducted by using the Promega Dual-Glo Luciferase reporter assay kit (Promega). Luminescence was measured using the POLARstar OPTIMA luminometer (BMG Labtech, Mornington, VIC, Australia). The ratio of firefly:Renilla luminescence for each well (nZ12) was calculated.
Statistical analysis
All data sets were represented as meanGS.E.M. Significant differences were determined using ANOVA with Dunnett's multiple comparison post-hoc test using results from experiments conducted at 8% O 2 as the reference level. A P value of P%0 . 05 was considered statistically significant.
Results
In the analysis of the data, we have focussed on the physiologically relevant oxygen concentrations that are present in vivo during placental development: 1, 3 and 8% O 2 .
Cell culture purity and viability
Trophoblast cell population purity ranged from 90 to 100%, as judged by cytokeratin-7 staining. Cell function and viability were assessed on day 4 of culture by measuring hCG and LDH concentrations in culture media (Fig. 1) (Fig. 3) .
I-TTR and Alexa-Fluor594-TTR uptake
Effect of T 4 binding on TTR internalisation by trophoblast cells was determined using 125 I-TTR uptake assays. 125 I-TTR uptake was measured in the presence and absence of 1 mM TTR and 10 mM T 4 . Significant increases in 125 I-TTR uptake were measured in cells cultured at 1% O 2 in comparison to 8% O 2 (1 . 85-fold increase P%0 . 01). Increases in TTR uptake in cells cultured at 3% O 2 (1 . 56-fold increase, P%0 . 01) and following 200 mM DFO treatment (1 . 58-fold increase, P%0 . 01) were also observed in comparison to cells cultured at 8% O 2 (Fig. 4) .
Internalisation of Alexa594-TTR by trophoblast cells was visualised as small red foci bordered by phalloidin (green)-stained actin filaments. Alexa594-TTR uptake was increased in cells cultured at 1 and 3% O 2 and following 200 mM DFO treatment in comparison to 8% O 2 (Fig. 5A) (Fig. 5B) .
TTR promoter activity TTR promoter activity was measured via luciferase production following transfection of reporter constructs into JEG-3 placental cells and cultured under low oxygen conditions (Fig. 6) . No significant differences in luciferase activity were measured between experimental groups in JEG-3 cells transfected with the pGL3-0 . 11 kb TTR promoter construct. A significant increase in luciferase activity was observed in JEG-3 cells transfected with the pGL3-0 . 65 
Discussion
Our results confirm our previous findings that the low placental oxygen levels reported in very early pregnancy may up-regulate TTR mRNA and protein levels and TTR secretion by trophoblast cells (Patel et al. 2010a ). Exposure to low oxygen levels also resulted in increased cellular uptake of TTR by primary trophoblasts, validating the use of JEG-3 cells as a model for examining interactions of TTR synthesis, secretion and uptake when exposed to different oxygen levels (Patel et al. 2010a) . TTR is a 56 kDa homotetrameric protein found in serum where it transports T 4 and retinol (Blake et al. 1971 , Palha 2002 . TTR is produced and secreted into the circulation by liver (Hamilton & Benson 2001) . TTR secretion by fetal tissues begins very early in gestation, with TTR secretion observed in the choroid plexus by week 8 and in the fetal liver by weeks 16-20 (Jacobsson 1989) . TTR is one of the three major TH transport proteins in serum (thyroxine-binding globulin (TBG) and albumin being the other two) and has a relatively high binding affinity for T 4 (7 . 0!10 7 M) and a serum concentration of w4 . 6!10 K6 M. Approximately 15% of circulating T 4 is bound to TTR (Hamilton & Benson 2001) . TTR is also synthesised and secreted by choroid plexus and is the predominant T 4 binding protein in cerebrospinal fluid (CSF; Herbert et al. 1986 ). TTR may be involved in transfer of serum T 4 to CSF and distribution of CSF T 4 into brain (Schreiber et al. 1995) . The retinal pigment epithelium also strongly expresses TTR and a role for T 4 delivery within the eye has been proposed (Cavallaro et al. 1990 ). Previous work from our group has demonstrated that the human placenta is also capable of producing albumin but not TBG. However, the role of albumin, which has a low affinity but high capacity for thyroid hormone binding, within the placenta is not yet known (McKinnon et al. 2005) .
A number of placental cell membrane thyroid hormone transporters have been described, including monocarboxylate transporters 8 and 10 (MCT8, MCT10); l-amino acid transporters 1 and 2 (Lat1, Lat2); and organic anion transporting polypeptide 1A2 and 4A1 (Oatp1A2, Oatp4A1), which have been postulated to mediate T 4 transport (Loubiere et al. 2010) . Only Lat1 has been reported to be affected (destabilised) by hypoxia (Boado et al. 2003) . We hypothesize that placental TTR is involved in transport of maternal T 4 to the fetus, as a carrier of T 4 or by delivery of T 4 to trophoblast T 4 membrane transporters or both.
During the first trimester, the placenta and fetus are exposed to relatively hypoxic conditions; oxygen concentrations early after implantation range from 1 to 3% (15-18 mmHg). These are optimal conditions for early placental and embryonic development (Rodesch et al. 1992 , Jauniaux et al. 2000 . Low oxygen levels stimulate trophoblast invasion into the maternal decidua, leading to increased uterine spiral artery remodelling and increased vascular compliance. By 8-10 weeks gestation, oxygen concentrations rise 3-5% (18 mmHg). Towards the end of the first trimester (11-12 weeks gestation), oxygen concentrations rise 7-10% (60 mmHg) and remain at this level until term (Rodesch et al. 1992) . These changes in placental oxygen concentrations are important for regulating trophoblast differentiation, maturation and function throughout gestation (Genbacev et al. 1997) . Before experimentation could be conducted, it is needed to be determined whether a functioning cell culture model was present. Therefore, both hCG and LDH were measured in cultured medium. hCG secretion was reduced at 1% O 2 , rising slightly at 3% O 2 and DFO and peaking at 8% O 2 . These findings are consistent with previous work in our laboratory, where hCG secretion was measured from BeWo placental cells cultured at low oxygen concentrations (Li et al. 2011) . No changes in LDH secretion between the experimental groups demonstrated good cell viability, as was observed in our previous study using JEG-3 placental cells (Patel et al. 2010a) .
In this study, TTR mRNA expression, protein levels and uptake of 125 I-TTR and Alexa-594-TTR in cells cultured in 1 and 3% O 2 were significantly greater than in trophoblasts cultured at 8%. In cells cultured at 21% O 2 , TTR mRNA and protein expression and TTR uptake were increased by treatment with 200 mM DFO, a hypoxia-mimicking agent. During hypoxia, HIF-1a drives the transcriptional response to oxygen deprivation by binding to hypoxia response elements within the promoters or enhancers of genes involved in nutrient exchange and energy expenditure (Bunn & Poyton 1996 , Wenger & Gassmann 1997 . HIF-1a activity is critical for normal placental development (Aplin 2000) . We have demonstrated up-regulation of HIF-1a in cells grown at 1 and 3% O 2 and in cells grown at 21% treated with DFO, suggesting that up-regulation of TTR at low oxygen concentrations may be driven by HIF-1a.
TTR promoter activity was also increased in JEG-3 cells cultured under low oxygen conditions, specifically in the pGL3-0 . 65 kb and pGL3-2 . 1 kb constructs. Previous work on TTR promoter function in liver cells demonstrated that a number of transcription factors must be bound for TTR expression to be activated and binding sites for these are found within the pGL3-0 . 65 kb and pGL3-2 . 1 kb constructs. These include hepatic nuclear factors 1, 3 and 4 (HNF-1, 3 and 4), CCAAT/enhancer binding protein (C/EBP) and activator protein-1 (AP-1; Fung et al. 1988 , Costa & Grayson 1991 . TTR expression has been detected in multiple tissue types including the placenta, choroid plexus and yolk-sac, and coordination of these transcription factors to illicit TTR expression will differ between tissues (Costa et al. 1990 , Qian et al. 1995 . This is perfectly demonstrated in the liver, where during the acute-phase response, TTR expression is rapidly down-regulated (Qian et al. 1995) . However, in the choroid plexus, there is no change in TTR expression under the same conditions (Costa et al. 1990 ). Additionally, early gestation yolk-sac production of TTR clearly occurs under hypoxic conditions and we have now also demonstrated this within placental cells, albeit in vitro. Within the placenta, HNF-3 (also known as FOXa2), C/EBP and AP-1 are found to be highly expressed throughout gestation and play a key role in activating the transcription of a number of important genes for fetal development (Bamberger et al. 2004a , 2004b , Friedman & Kaestner 2006 . It is also interesting to note that both C/EBP and AP-1 are up-regulated under hypoxic conditions and closely interact with HIF-1a, leading to the transcription of specific gene targets (Cummins & Taylor 2005 , Janardhan 2008 . In this study, we have demonstrated increased TTR promoter activity in cells cultured under low oxygen culture conditions; however, further in-depth analysis of placental transcription factors will increase our understanding of placental specific regulation of TTR expression.
There is also a growing body of evidence to suggest that type 3 deiodinase (D3) activity is regulated by hypoxia in a tissue-specific manner (Simonides et al. 2008) . D3 is highly expressed in the placenta, more so earlier in gestation to actively regulate the amount of maternal T 4 being presented to the fetus (Chan et al. 2003) . Therefore, we postulate that TTR binding may play a role in protecting maternal T 4 from active deiodination within the placenta, allowing greater concentrations of T 4 to enter the fetal circulation, particularly early in gestation where T 4 is so critical for neurological development. Oxygen appears to be an important regulator of trophoblast TTR expression in vitro. While enhancement of TTR in the early, relatively hypoxic placenta (at a time when the fetus is absolutely dependent on maternal transfer of T 4 ) has teleological appeal, however, many other unknown in vivo factors undoubtedly play a role in the regulation of TTR. Therefore, this topic deserves further investigation.
Conclusion
Our study has unequivocally demonstrated up-regulation of TTR expression and TTR uptake by primary cytotrophoblast cells cultured at low oxygen concentrations. This may suggest increased transplacental delivery of T 4 to the fetus during the first trimester of pregnancy.
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